STX16 and nonpapillary renal cell carcinoma: Our results represent the first detailed exploration of STX16 expression in ccRCC and are consistent with reports of altered STX16 levels in other malignancies, such as esophageal squamous cell carcinoma, suggesting STX16 might act as a shared oncogenic effector across epithelial malignancies10.